The transcription factor B-cell lymphoma (BCL)-6 modulates pancreatic β-cell inflammatory responses

Endocrinology

Volumn 152, Issue 2, 2011, Pages 447-456

  Igoillo Esteve, Mariana ^a   Gurzov, Esteban N ^a   Eizirik, Décio L ^a   Cnop, Miriam ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEATH RECEPTOR 5; FAS ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROLACTIN; PROTEIN BCL 6; TRANSCRIPTION FACTOR JUNB;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CYTOKINES; FLUORESCENT ANTIBODY TECHNIQUE; FORSKOLIN; INSULIN-SECRETING CELLS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES; POLYMERASE CHAIN REACTION; PROLACTIN; PROTO-ONCOGENE PROTEINS C-BCL-6; RATS; RATS, WISTAR; VENOMS;

EID: 79951655090     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0790     Document Type: Article

References (67)

1. Eizirik DL, Mandrup-Poulsen T 2001 A choice of death - the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115-2133 (Pubitemid 34015464)
2. Eizirik DL, Colli ML, Ortis F 2009 The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219-226
3. Mathis D, Vence L, Benoist C 2001 β-cell death during progression to diabetes. Nature 414:792-798
4. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhøffer M, Ørntoft T, Eizirik DL 2001 A comprehensive analysis of cytokine-induced and NF-κB-dependent genes in primary rat pancreatic β-cells. J Biol Chem 276:48879-48886
5. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, Klein T, Serup P, Eizirik DL, Melloul D 2006 Conditional and specific NF-κB blockade protects pancreatic β-cells from diabetogenic agents. Proc Natl Acad Sci USA 103:5072-5077
6. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL 2001 Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50:2219-2224 (Pubitemid 33641904)
7. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ 2000 Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator- activated receptor β(δ). Mol Cell Biol 20: 5119-5128 (Pubitemid 30431565)
8. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q 2004 Cardiomyocyte- restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245-1250 (Pubitemid 39540443)
9. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J 2003 Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924-15929 (Pubitemid 38021091)
10. Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Evans RM, Curtiss LK 2003 Transcriptional repression of atherogenic inflammation: modulation by PPARδ. Science 302:453-457 (Pubitemid 37296272)
11. Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP, Leprince D 1995 The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ 6:1495-1503
12. Chang CC, Ye BH, Chaganti RS, Dalla-Favera R 1996 BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA 93:6947-6952 (Pubitemid 26243480)
13. Seyfert VL, Allman D, He Y, Staudt LM 1996 Transcriptional repression by the proto-oncogene BCL-6. Oncogene 12:2331-2342 (Pubitemid 26192713)
14. Huynh KD, Fischle W, Verdin E, Bardwell VJ 2000 BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14:1810-1823 (Pubitemid 30602999)
15. Costoya JA 2007 Functional analysis of the role of POK transcriptional repressors. Brief Funct Genomic Proteomic 6:8-18 (Pubitemid 351721044)
16. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O 1998 The LAZ3(BCL-6) oncoprotein recruits a SMRT/ mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 26:4645-4651 (Pubitemid 28466611)
17. Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, Leutz A, Kerckaert JP, Evans RM, Leprince D 1997 Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci USA 94:10762-10767 (Pubitemid 27430808)
18. Wong CW, Privalsky ML 1998 Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARα, and BCL-6. J Biol Chem 273:27695-27702 (Pubitemid 28500495)
19. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM 1997 Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592 (Pubitemid 27193682)
20. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R 1997 The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161-170
21. Toney LM, Cattoretti G, Graf JA, Merghoub T, Pandolfi PP, Dalla- Favera R, Ye BH, Dent AL 2000 BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol 1:214-220
22. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM 2000 BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212
23. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C 1993 LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5:66-70 (Pubitemid 23261521)
24. Fukuda T, Miki T, Yoshida T, Hatano M, Ohashi K, Hirosawa S, Tokuhisa T 1995 The murine BCL6 gene is induced in activated lymphocytes as an immediate early gene. Oncogene 11:1657-1663
25. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR, Staudt LM 1996 BCL-6 expression during B-cell activation. Blood 87: 5257-5268 (Pubitemid 26189869)
26. Takata Y, Liu J, Yin F, Collins AR, Lyon CJ, Lee CH, Atkins AR, Downes M, Barish GD, Evans RM, Hsueh WA, Tangirala RK 2008 PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 105:4277-4282 (Pubitemid 351754371)
27. Kumagai T, Miki T, Kikuchi M, Fukuda T, Miyasaka N, Kamiyama R, Hirosawa S 1999 The proto-oncogene Bcl6 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells. Oncogene 18:467-475 (Pubitemid 29060622)
28. Yamochi T, Kaneita Y, Akiyama T, Mori S, Moriyama M 1999 Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L). Oncogene 18:487-494 (Pubitemid 29060624)
29. Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP, Montarras D, Pinset C, Lindon C 1999 Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci. Oncogene 18:5063-5075 (Pubitemid 29443752)
30. Kharroubi I, Lee CH, Hekerman P, Darville MI, Evans RM, Eizirik DL, Cnop M 2006 BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic β-cells. Diabetologia 49: 2350-2358 (Pubitemid 44359096)
31. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK 2007 Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806-809 (Pubitemid 351411773)
32. Glauser DA, Schlegel W 2009 The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β-cells. J Recept Signal Transduct Res 29:293-298
33. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB 1992 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178
34. Ortis F, Cardozo AK, Crispim D, Störling J, Mandrup-Poulsen T, Eizirik DL 2006 Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory NF-κB activation. Mol Endocrinol 20:1867-1879 (Pubitemid 44148090)
35. Ling Z, Hannaert JC, Pipeleers D 1994 Effect of nutrients, hormones and serum on survival of rat islet beta-cells in culture. Diabetologia 37:15-21 (Pubitemid 24044702)
36. Rasschaert J, Ladrière L, Urbain M, Dogusan Z, Katabua B, Sato S, Akira S, Gysemans C, Mathieu C, Eizirik DL 2005 Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-γ-induced apoptosis in primary pancreatic β-cells. J Biol Chem 280: 33984-33991 (Pubitemid 41443119)
37. Darville MI, Eizirik DL 1998 Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101-1108 (Pubitemid 28394417)
38. Darville MI, Eizirik DL 2001 Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-κB and C/EBP. Diabetes 50:1741-1748 (Pubitemid 33641591)
39. Kutlu B, Cardozo AK, Darville MI, Kruhøffer M, Magnusson N, Ørntoft T, Eizirik DL 2003 Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701-2719
40. Cunha DA, Ladriére L, Ortis F, Igoillo-Esteve M, Gurzov EN, Lupi R, Marchetti P, Eizirik DL, Cnop M 2009 Glucagon-like peptide-1 agonists protect pancreatic β-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58: 2851-2862
41. Moore F, Colli ML, Cnop M, Esteve MI, Cardozo AK, Cunha DA, Bugliani M, Marchetti P, Eizirik DL 2009 PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ-induced pancreatic β-cell apoptosis. Diabetes 58:1283-1291
42. Cunha DA, Hekerman P, Ladrière L, Bazarra-Castro A, Ortis F, Wakeham MC, Moore F, Rasschaert J, Cardozo AK, Bellomo E, Overbergh L, Mathieu C, Lupi R, Hai T, Herchuelz A, Marchetti P, Rutter GA, Eizirik DL, Cnop M 2008 Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 121:2308-2318
43. Hoorens A, Van de Casteele M, Klöppel G, Pipeleers D 1996 Glucose promotes survival of rat pancreatic β-cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568-1574 (Pubitemid 26327866)
44. Ladrière L, Igoillo-Esteve M, Cunha DA, Brion JP, Bugliani M, Marchetti P, Eizirik DL, Cnop M 2010 Enhanced signaling downstream of ribonucleic acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets. J Clin Endocrinol Metab 95:1442-1449
45. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL 2001 Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in IL-1β-exposed human and rat islet cells. Diabetologia 44:325-332 (Pubitemid 32234459)
46. Overbergh L, Valckx D, Waer M, Mathieu C 1999 Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312 (Pubitemid 29213178)
47. Gurzov EN, Ortis F, Bakiri L, Wagner EF, Eizirik DL 2008 JunB inhibits ER stress and apoptosis in pancreatic β-cells. PLoS One 3:e3030
48. Liuwantara D, Elliot M, Smith MW, Yam AO, Walters SN, Marino E, McShea A, Grey ST 2006 Nuclear factor-κB regulates β-cell death: a critical role for A20 in β-cell protection. Diabetes 55:2491-2501 (Pubitemid 44871149)
49. Gurzov EN, Ortis F, Cunha DA, Gosset G, Li M, Cardozo AK, Eizirik DL 2009 Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis. Cell Death Differ 16:1539-1550
50. Li Z, Wang X, Yu RY, Ding BB, Yu JJ, Dai XM, Naganuma A, Stanley ER, Ye BH 2005 BCL-6 negatively regulates expression of the NF-κB1 p105/p50 subunit. J Immunol 174:205-214 (Pubitemid 40007406)
51. Perez-Rosado A, Artiga M, Vargiu P, Sanchez-Aguilera A, Alvarez- Barrientos A, Piris M 2008 BCL6 represses NF-κB activity in diffuse large B-cell lymphomas. J Pathol 214:498-507 (Pubitemid 351340570)
52. Brelje TC, Svensson AM, Stout LE, Bhagroo NV, Sorenson RL 2002 An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans. J Histochem Cytochem 50:365-383 (Pubitemid 34171060)
53. Brelje TC, Stout LE, Bhagroo NV, Sorenson RL 2004 Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of Langerhans. Endocrinology 145:4162-4175 (Pubitemid 39120565)
54. Schuringa JJ, Chung KY, Morrone G, Moore MA 2004 Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. J Exp Med 200:623-635 (Pubitemid 39258311)
55. Walker SR, Nelson EA, Frank DA 2007 STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 26:224-233 (Pubitemid 46095733)
56. Scheeren FA, Naspetti M, Diehl S, Schotte R, Nagasawa M, Wijnands E, Gimeno R, Vyth-Dreese FA, Blom B, Spits H 2005 STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 6:303-313 (Pubitemid 41724768)
57. Nielsen JH 1982 Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets. Endocrinology 110:600-606 (Pubitemid 12162957)
58. Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, Carlsson C 2001 Regulation of β-cell mass by hormones and growth factors. Diabetes 50(Suppl 1):S25-S29 (Pubitemid 32148211)
59. Sorenson RL, Brelje TC 2009 Prolactin receptors are critical to the adaptation of islets to pregnancy. Endocrinology 150:1566-1569
60. Yu-Lee LY 2002 Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 57:435-455
61. Holstad M, Sandler S 1999 Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice. J Endocrinol 163:229-234
62. Atwater I, Gondos B, DiBartolomeo R, Bazaes R, Jovanovic L 2002 Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse. Ann Clin Lab Sci 32:87-92 (Pubitemid 34137437)
63. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC, Simone F, Birkenbach M, Montag A, Sadhu A, Zeleznik-Le N, McKeithan TW 2002 The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci USA 99: 2860-2865 (Pubitemid 34240551)
64. Kojima S, Hatano M, Okada S, Fukuda T, Toyama Y, Yuasa S, Ito H, Tokuhisa T 2001 Testicular germ cell apoptosis in Bcl6-deficient mice. Development 128:57-65 (Pubitemid 32094385)
65. Vasanwala FH, Kusam S, Toney LM, Dent AL 2002 Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 169:1922-1929 (Pubitemid 34857655)
66. Colli ML, Moore F, Gurzov EN, Ortis F, Eizirik DL 2010 MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 19:135-146
67. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330 (Pubitemid 44465460)